Drug Treatment Reduces Risk of Skin Cancer in Transplant Patients

Scripted’s talented community of freelance writers have a variety of expertise and specialties. While many of our customers hire writers to execute their content marketing strategy, our writers deliver high-quality content in many formats. You can find content writers, blog writers, ghostwriters, and SEO writers all with experience in your niche.

The following is a an example of a Healthcare and Sciences blog post:


It is well documented that solid organ transplant recipients (OTRs) are at greater risk of developing skin cancer following transplant surgery. However, a new study conducted by Harvard Medical School researchers found that an immunosuppressive drug lowers the risk of subsequent skin cancer following an initial posttransplant cancer diagnosis. The findings lead researchers to say a low-dose of sirolimus may prove beneficial for patients who develop multiple or high risk skin cancers following a solid organ transplant. “In this mixed-organ cohort of OTRs, patients taking sirolimus after developing posttransplant skin cancer had a lower risk of developing subsequent skin cancer with no increased risk for overall mortality,” the researchers wrote. “Gradual conversion to a low-dose [mammalian target of rapamycin]-based regimen may be considered in patients who develop multiple or high-risk skin cancers to decrease their skin cancer burden. Further studies are needed to define optimal conversion regimens and dosing in such scenarios.” Sirolimus is an immunosuppressive drug used in combination with other medications to prevent rejection of kidney transplants. Prior studies indicated a relationship between lower rates of skin cancer in OTRs who were treated with sirolimus. "However, little information exists on the use of sirolimus for the prevention of skin cancer in nonrenal OTRs or those already diagnosed as having a posttransplant cancer," the study's authors wrote. The study was published in the Jan. 20, 2016 issue of JAMA Dermatology. In the retrospective cohort study, researchers reviewed medical records of OTRs diagnosed with posttransplant cancer between the years 2000 and 2008. The research team identified which organ was transplanted, whether the patients had pretransplant and/or post transplant cancers and any immunosuppressive medications the patients took. Patients were treated at Brigham and Women's Hospital and Massachusetts General Hospital. The team looked at 329 solid organ transplant recipients who developed any type of cancer following transplant surgery. The majority were men with a mean age of 56 years. Of the OTRs: 17.6 percent received a heart transplant, 53.8 percent received a kidney transplant, 16.4 percent received a lung transplant, 10.3 percent received a liver transplant, 1.8 percent received a mixed-organ transplant. Overall, nearly 40 percent of study participants were diagnosed with a second post-transplant cancer. The majority of diagnosed malignancies (88.5 percent) were skin cancers. Of the OTRs included in the study, nearly 30 percent (97 patients) underwent sirolimus therapy after the initial cancer diagnosis. Among the patients who received sirolimus, there was an 11.6 percent reduction in the risk of developing a secondary skin cancer following the initial cancer diagnosis. In the group that received sirolimus, 26.8 percent of patients developed a secondary skin cancer compared with 38.4 percent who did develop skin cancer in the group that did not receive the drug. "Conversion to sirolimus therapy may be considered in OTRs who develop cancer if the risk for skin cancer is of concern,” the authors wrote in the study's conclusion. “Larger studies are needed to quantify sirolimus-associated risk reduction for other cancer types.”


Chelsea A.

Chelsea A.

New Orleans, Louisiana, United States

A former newspaper journalist, Chelsea Adams is a freelance writer specializing in health, wellness and lifestyles topics. A native Tennessean, she makes her home in the Midwest with her husband and two daughters. Learn more about her transition from the mountains to the prair...

Jobs Completed 69 Customer Ratings 4 Job Success 65/69 (94%)

Other content marketing examples from Chelsea A.

Dubai Holiday Packages for Wotif.com

Dubai Emirate Holiday PackagesIf you're like many people, you may think of Dubai as simply a play... Read More

Why Gardening is a Great Way to Relieve Stress

The next time you feel stressed, don’t reach for a sugary snack. Grab the gardening shears instea... Read More

Similar content marketing examples from other writers

Reduce No-Shows: The 4 Best Digital Appointment Reminders for Health Care Providers

Cancellations are problematic, but no-shows are a bottom-line killer for health care providers. ... Read More

3 Roadblocks to Installing Electronic Health Records (and How to Overcome Them)

The difficulty of installing electronic health records is made more challenging by cost and secur... Read More

Alleviating Patients' Fear of Electronic Health Records

 Healthcare providers need electronic health records. Patients need to feel comfortable with thei... Read More

Using Alternative Medicine: Is it Safe?

Alternative medicine is believed by some to be the true route to healthy living. Rather than argu... Read More

For Cancer Prevention, Experts Recommend 9-a-Day

Nutrition is arguably the most important aspect of good health. Do the standard serving sizes app... Read More